COMPARISON OF MEDICAL COSTS AND UTILIZATION ASSOCIATED WITH USE OF ZIPRASIDONE AND OLANZAPINE AMONG SCHIZOPHRENIA AND BIPOLAR DISORDER PATIENTS

被引：1
|
作者：
Jiang, Y. [1 ]
McGinnis, J. J. [1 ]
Ni, W. [1 ]
机构：
[1] Univ So Calif, Sch Pharm, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.297
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH14
引用
收藏
页码：A768 / A768
页数：1
相关论文
共 50 条
  • [1] Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA
    Yawen Jiang
    Weiyi Ni
    Justin J. McGinnis
    [J]. Clinical Drug Investigation, 2014, 34 : 491 - 499
  • [2] Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA
    Jiang, Yawen
    Ni, Weiyi
    McGinnis, Justin J.
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (07) : 491 - 499
  • [3] Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
    Gao, Keming
    Mackle, Mary
    Cazorla, Pilar
    Zhao, Jun
    Szegedi, Armin
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1145 - 1157
  • [4] Samidorphan for the treatment of weight gain associated with olanzapine in patients with schizophrenia and bipolar disorder
    Gao, Junfa
    Li, Junsheng
    Lu, Xiuhua
    Yang, Junyi
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (09) : 1011 - 1016
  • [5] Ziprasidone dosing study in pediatric patients with bipolar disorder, schizophrenia, or schizoaffectwe disorder
    Delbello, M
    Versavel, M
    Ice, K
    Miceli, J
    Kowatch, R
    Keller, D
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 80 - 81
  • [6] Ziprasidone dosing study in pediatric patients with bipolar disorder, schizophrenia, or schizoaffective disorder
    Versavel, M
    DelBello, MP
    Ice, K
    Kowatch, R
    Keller, D
    Miceli, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S122 - S123
  • [7] Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine
    Fuller, MA
    Shermock, KM
    Secic, M
    Laich, JS
    Durkin, MB
    [J]. PSYCHIATRIC SERVICES, 2002, 53 (07) : 855 - 860
  • [8] Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia
    Henderson, David C.
    Fan, Xiaoduo
    Copeland, Paul M.
    Sharma, Bikash
    Borba, Christina P.
    Forstbauer, Sharon I.
    Miley, Kate
    Boxill, Ryan
    Freudenreich, Oliver
    Cather, Corrine
    Evins, Anne E.
    Goff, Donald C.
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (03) : 225 - 232
  • [9] ANTIPSYCHOTICS UTILIZATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH SCHIZOPHRENIA IN CHINESE PATIENTS
    Fan, C. S.
    Hs, Q.
    Chen, B. B.
    Wang, F. X.
    Jiang, L. T.
    Zhao, M.
    Wu, J. H.
    [J]. VALUE IN HEALTH, 2019, 22 : S760 - S760
  • [10] HEALTH-CARE UTILIZATION COSTS AMONG SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE OR RISPERIDONE IN JAPAN
    Nakahara, N.
    Kobayashi, M.
    Kamae, I
    Inagaki, A.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A554 - A554
12345